United Kingdom· GB-APID-17902311000001105
Erythromycin ethyl succinate 125mg/5ml oral suspension
A medicinal product containing erythromycin ethyl succinate, registered in United Kingdom by Phoenix Healthcare Distribution Ltd.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Erythromycin ethyl succinate
- Manufacturer
- Phoenix Healthcare Distribution Ltd
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Erythromycin ethyl succinate in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesE.E.SCarnegie Pharmaceuticals LLC
- FinlandAbboticinAbbott Scandinavia AB
- BelgiumErythrocine 250 mg/5 mlAmdipharm
- IrelandPrimacine 125 mg/5 ml Granules for Oral SuspensionPinewood Laboratories Ltd
- GermanyErythrocin NeoAmdipharm Limited
Authorised across Europe · EMA
The same active substance is authorised in 10 EEA countries. Names it is sold under:
- Belgium · Erythroforte
- Germany · Erythrocin Neo
- Denmark · Abboticin, Abboticin Novum
- Spain · Eritromicina Normon, Pantomicina
- France · Ery Enfants, Erythrocine
- Ireland · Erythroped, Erythroped Pi
- Luxembourg · Erythrocine, Erythroforte
- Malta · Primacine
- Norway · Abboticin Es
- Portugal · E.S.E. 500, Eritrocina
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0a4ffdce-e057-490a-aa38-60b84a492155 GET /v1/drugs/0a4ffdce-e057-490a-aa38-60b84a492155?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "17902311000001105",
"desc": "Erythromycin ethyl succinate 125mg/5ml oral suspension (Phoenix Healthcare Distribution Ltd)",
"form": "Oral suspension",
"vpid": "41948911000001103",
"source": "dmd",
"vtm_id": "36408511000001102",
"strength": "25 mg",
"substance": "Erythromycin ethyl succinate",
"ingredient": "Erythromycin ethyl succinate",
"supplier_code": "17845311000001104"
}See everything about erythromycin ethyl succinate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.